Until a decade ago, epilepsy research had focused mainly on alterations of neuronal activities and excitability. Such neurocentric emphasis has neglected the role of glia and involvement of inflammation in the pathogenesis of epilepsy. It is becoming clear that immune and inflammatory reactions do occur in the brain despite the brain's lack of conventional lymphatic drainage and graft acceptance and the presence of vascular brain barrier that tightly regulates infiltration of blood monocytes and lymphocytes. The critical roles of brain-resident immune mediators and of brain-infiltrating peripheral leukocytes are increasingly recognized. Inflammatory processes, including activation of microglia and astrocytes and production of proinflammatory cytokines and related molecules, occur in human epilepsy as well as in experimental models of epilepsy. Immune mechanism that underlies evolution of drug-resistant epilepsy and epileptic encephalopathy represents a new target and will aid in development of novel immunotherapeutic drugs and therapies against the key constituents in immune pathways.
The long-term cognitive and socioeconomic consequences of intractable epilepsy that begins in infancy are truly devastating. [1] [2] [3] Antiepileptic drugs are not only inadequate to control seizures in nearly 30% of children with epilepsy, 4 but also fail to spare the developing brain from epileptogenic insults, to modify disease progression or to promote recovery after seizures. Such drugs do little to improve cognitive function, yet they can cause detrimental cognitive and mood altering side effects to further burden the development of children with epilepsy. 1, 5 New therapeutic approaches that prevent the progression of epilepsy and limit cellular injury associated with seizures are critically needed.
For many decades, the functional roles of inflammation and the immune system in childhood epilepsy have been suspected since pediatric infectious and autoimmune diseases are often accompanied by recurrent seizures. Also, immunotherapy effectively treats refractory seizures in pediatric epilepsy syndromes. 6, 7 Active inflammation has been detected not only in prototypical inflammatory epilepsies such as Rasmussen's encephalitis or limbic encephalitis, but also in patients with drug-resistant epilepsy of diverse causes and in many animal models of seizures. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] A genome-wide search to identify novel drug targets in the author's laboratory has revealed that proinflammatory molecules are one of the most abundant functional groups acutely upregulated after a prolonged seizure, suggesting these may be therapeutic molecular targets in the epileptogenic process. In surgically resected cortical tissue from children with intractable epilepsy, the author has shown that there is abundant cell injury and marked glial activation. 20 In addition, complement components, metalloproteinases, adhesion molecules and immune receptors, the markers for peripheral leukocytes and adaptive immunity, were upregulated in resected hippocampal tissue, suggesting that the blood-brain barrier is compromised in the chronic epileptic state.
Collectively, these observations provide strong evidence for a functional role for innate and adaptive immune responses in childhood epilepsy. To test the hypothesis of a causative role of inflammation and immunity in epileptogenesis, the author employed a murine model of chemoconvulsant, kainic acidinduced status epilepticus followed by "second hit" kainic acid-induced status epilepticus later in life. 21 The author utilized her 2-hit model to test the efficacy of anti-inflammatory drugs and enriched environment to block the epileptogenic effect of early-life seizures. The author directly address the role of central nervous system-resident and peripheral inflammatory cells in the epileptogenic process by using transgenic reporter mice and a sensitive flow cytometry-based analysis of inflammatory cells in resected brain tissue from children with drug-resistant epilepsy. The author aimed to evaluate the relative contributions of innate immunity (mediated by astrocytes, microglia and infiltrating mononuclear cells) and adaptive immunity (mediated by infiltrating lymphocytes) to the epileptogenic process.
Childhood Epilepsy and Their Devastating Neurological Sequelae
The rapidly developing brains of infants and children are susceptible to seizures. The incidence of convulsive status epilepticus, prolonged or repeated seizures that last over 30 minutes, is highest among children less than 1 year of age. 22, 23 For many people with epilepsy, seizures start before 10 years of age. 24 In the United States alone, approximately 325 000 children from 5 to 14 years of age have active epilepsy 25 and among 300 000 patients who visit hospitals for a newly recognized seizure each year, 40% are children under 18 years of age. 26 A prolonged seizure can have both acute and long-lasting effects on the developing brain. At present, there is no effective treatment to promote recovery and neuron regeneration after seizures. Currently available antiepileptic drugs do little to improve cognitive function; in fact, studies in children and animals have shown that antiepileptic drugs can be harmful. 27, 28 The proposed project specifically addresses much needed novel therapeutic strategies that target the immune response as an underlying cause for the chronic epileptogenic effects of early-life seizures.
Children with epilepsy not only suffer from cognitive impairment, attention deficit hyperactivity disorder or catastrophic rage, but are more likely to remain unemployed, unmarried and childless in adulthood. 1, 2 Behavioral problems, school failure and memory impairment are common among children with epilepsy. [29] [30] [31] [32] [33] Even if seizures typically remit after early childhood, the long-term cognitive and socioeconomic prognosis for these children can be poor, especially if seizure onset occurred before 2 years of age. [1] [2] [3] Thus, it is critically important to find ways to minimize the immediate impact of seizures to decrease their long-term consequences. The author hypothesized that innate and adaptive immune responses may play a causal role in mediating the long-term epileptogenic effects of prolonged convulsions as well as acute injury to neuronal synapses. Suppression and normalization of excessive production of inflammatory mediators by antiinflammatory therapy may therefore prevent status epilepticus-induced cell injury and increases in susceptibility to subsequent seizures, and hasten recovery of neuronal function.
Emerging Role of Innate and Adaptive Immunity in Epilepsy
For centuries, scientists in epilepsy research have had a neurocentric view of the world. The reason for such a focus on neurons (deemed the "noble elements" by Ramón y Cajal) by epileptologists and epilepsy researchers is understandable since, after all, neurons are the excitable element in the brain, and epilepsy is a condition characterized by enduring changes in neuronal excitability. Yet, in the brain, neurons are vastly outnumbered by glia, which strongly influence neurons and their ability to process information. 34 The brain exhibits a robust innate immune response mediated by central nervous system-resident immune cells, microglia and astrocytes. [34] [35] [36] [37] [38] Such neuroinflammation was previously viewed as an epiphenomenon, a passive bystander effect that occurs when damaged neurons elicit a response from glia. Recently, however, it has become increasingly clear that dysregulation of the normally reparative innate immune responses of glia may instead cause exacerbation of pathology and neuronal dysfunction. [8] [9] [10] [11] [12] [13] [14] [15] Aberrant or uncontrolled neuroinflammation that persists beyond elimination of the initial provoking stimulus-seizures in the epileptic brain, for example-can have a profound detrimental impact on neuron function, including a hyperexcitable state, encephalopathy and cognitive decline. 39 Largely due to the blood-brain barrier, the brain has been considered to be an immunoprivileged tissue that exhibits dampened adaptive immunity in response to injury or infection. This notion has recently been challenged in epilepsy research; breakdown of the blood-brain barrier has been implicated in the initiation, progression and perpetuation of seizures in animal models. 40, 41 In addition, it is now well established that activated mononuclear leukocytes (T cells, macrophages and dendritic cells) can traverse the bloodbrain barrier using homing molecules such as VLA-4, 42 the target for the multiple sclerosis drug, Tysabri. 43, 44 The potential causative role of innate and adaptive immunity in the development of chronic epilepsy that starts in childhood has not been adequately explored.
Innate Immunity (Neuroinflammation) in Epileptogenesis-Identification of a Therapeutically Accessible Target
With the aim of identifying new molecular targets for drug development, the author's laboratory has performed a global survey of changes in gene expression after kainic acid-induced status epilepticus in the rat (a well-established animal model of temporal lobe epilepsy) and compared these genes with those up-regulated in surgical specimens from patients with intractable temporal lobe epilepsy. Previous work by others has primarily focused on the roles of IL-1b and glial activation in propagating the inflammatory response resulting from seizures. [16] [17] [18] [19] The author noted that the inflammatory response associated with the cytokines TNF-a, IL-1b, IL-6, and IL-18 in the acute period up to 72 hours and by IL-18 in the subacute period through the 10-day time point. In addition, a panoply of other immune system genes are upregulated including chemokines, complement components, metalloproteinases and their inhibitors, tPA and its inhibitor, annexins, adhesion molecules, immune receptors such as MHC molecules and Fc receptors, galectins, and heat shock proteins ( Figure 1 ). According to a comprehensive, composite functional and pathway-related ontological online database (KEGG pathway, Gene Ontology, AmiGO, Rat Genome Database, Panther, Affymetrix, NetAffx and Pathway Interactions Database), genes coding for classical inflammatory mediators are among those most significantly upregulated acutely after a prolonged seizure. These inflammation/immune-related genes remain persistently elevated only in mature rats that show seizure-induced cell death and subsequently develop spontaneous recurrent seizures, but not in immature animals that develop neither cell death nor epilepsy. This suggests that an excessive inflammatory or immune response, that persists long after inciting insults have abated, may exacerbate seizure-induced neuronal injury and hyperexcitability. Temporal lobe epilepsy patients with intractable seizures and rats exposed to status epilepticus show up-regulation of many of the same genes within all of these categories (common genes denoted with an asterisk in Figure 1 ). Seizure-induced glia activation and upregulation of cytokines, chemokines, adhesion molecules and matrix metalloproteinase expression are likely to compromise blood-brain barrier integrity and allow infiltration of leukocytes into the central nervous system. 45 There was indeed evidence for involvement of adaptive immune system and detection of peripheral CD4
þ T cells (immune receptors- Figure 1 ) in the resected hippocampal tissue, suggesting possible blood-brain barrier breakdown.
A Postnatal Peak in Microglial Development is Correlated with Heightened Sensitivity to Seizure Triggers
Microglia are poised to take a central position in the seizureinduced inflammatory response since they are both the primary source and target of many cytokines and chemokines in the central nervous system. 46 Widespread microglia activation accompanying neuronal injury has been described in rodent models of acute seizures. 35, 47 The author's microarray data have also implicated microglial activation as one of the earliest events following kainic acid-induced seizures in both P15 and P30 rats. Explosive synaptogenesis and synaptic pruning occur in the hippocampus during the first 2 weeks of postnatal life, coincident with a heightened susceptibility to seizures in rodents. To determine the temporal correlation between microglial development and age-dependent susceptibility and response to seizures, the author quantified developmental changes in basal microglia levels and seizureinduced microglial activation in the hippocampus of Cx3Cr1GFP/þ transgenic mice. Basal levels of microglia were quantified in the hippocampi of Cx3Cr1GFP /þ mice at P0, P5, P10, P15, P20, P25, P30, P40, and P60. Seizure susceptibility and seizure-induced microglial activation were assessed in response to febrile seizures (lipopolysaccharide followed by hyperthermia) and kainic acid-induced status epilepticus. The density of microglia within the hippocampus increased rapidly after birth, reaching a peak during the second week of life-the age at which the animals became most vulnerable to seizure triggers. In addition, this peak of microglial development and seizure vulnerability during the second postnatal week represented the time of maximal seizureinduced microglia activation. Overreactive innate immunity mediated by activated microglia may exacerbate acute injury to neuronal synapses and contribute to the long-term epileptogenic effects of early-life seizures. Anti-inflammatory therapy targeting excessive production of inflammatory mediators by activated microglia, therefore, may be an effective agespecific therapeutic strategy to minimize neuronal dysfunction and prevent increases in susceptibility to subsequent seizures in developing animals. 
Two-Hit Hypothesis of EpileptogenesisModeling the Epileptogenic Effect of Early Life Seizures
Seizures in immature animals cause subtle functional changes even without causing cell death and alter the response to seizures later in life. 21, [49] [50] [51] [52] [53] Hyperthermia, hypoxia, flurothyl or kainic acid-induced seizures during the first 2 weeks of life in rat pups enhance long-term excitability within the hippocampal neuronal network. 21, [54] [55] [56] The author has shown that the priming effect of perinatal hypoxia could be reversed if acute seizures were blocked, 57 or if AMPA/kainic acid type glutamate receptors were blocked immediately following seizures. 58 The author has further shown a link between glial activation after early-life seizures for later-life seizure susceptibility and neurodegenration. 59 Available data thus suggest that seizures in the immature brain can cause permanent alterations to render the brain more susceptible to subsequent seizures and that glial activation and specific inflammatory mediators may be important in priming the brain for subsequent neuronal excitability and injury. TNF-a appears to play a critical role in mediating long-lasting increase in seizure susceptibility following lipopolysaccharide injection during the second week of life. 60 Microglia express AMPA/kainic acid type glutamate receptors on their surfaces and activation of these receptors leads to TNF-a production. 61 This raises the intriguing possibility that the AMPA receptor antagonists that the author used after hypoxia were effective in preventing later increases in seizure-induced neuronal injury, at least in part, by blocking microglial activation. The author has directly tested this possibility and determine whether blocking innate immunity, microglial activation, prevent early life seizure-induced increases in seizure susceptibility and examine the causative role of seizure-induced acute immune response in rendering the developing brain chronically seizure-prone.
Minocycline Attenuates Microglia Activation and Blocks the Long-Term Epileptogenic Effects of Early Life Seizures
To address the role of activated microglia in the pathogenesis of childhood epilepsy, the author first examined the time course of microglia activation following kainic acid-induced status epilepticus in Cx3cr1GFP/þ transgenic mice whose microglia are fluorescently labeled. The author then determined whether this seizure-induced microglia activation primes the central immune response to overreact and to increase the susceptibility to a second seizure later in life. The author used an inhibitor of microglia activation, minocycline, to block the seizure-induced inflammation to determine whether innate immunity plays a causal role in mediating the long-term epileptogenic effects of early-life seizure. First status epilepticus was induced at postnatal day (P) 25 and a second status at P39. Kainic acidinduced status epilepticus at P25 caused nearly a 2-fold increase in microglia activation within 24 h. Significant seizure-induced activation persisted for 7 days and returned to baseline by 14 days. P39 animals with prior exposure to kainic acid-induced status epilepticus not only responded with greater microglial activation in response to "second hit" of kainic acid, but shorter latency to express seizures. Inhibition of seizure-induced inflammation by 7-day minocycline posttreatment abrogated both the exaggerated microglia activation and the increased susceptibility to the second seizure later in life. The priming effect of early-life seizures is accompanied by modified and rapidly reactivated microglia. Anti-inflammatory therapy after status epilepticus may be useful to block the epileptogenic process and mitigate the long-term damaging effects of early-life seizures. 62 
Postseizure Acute Dexamethasone Treatment Mitigates Epileptogenic Effect of Early-Life Status Epilepticus
Chronic epilepsy can start with an isolated early life prolonged seizures, often febrile, followed by a period of remission and then the reemergence of seizures later in life. Comprehensive treatment for early life seizures thus includes the management of both acute and chronic effects of severe prolonged seizures. Administering 3 different widely available anti-inflammatory agents, the author examined whether the early life anti-inflammatory treatment reduced future susceptibility to a "second hit" and reversed the heightened microglia activation and cell death after later-life seizures. In the author's "2-hit"-kainic acid model in rats, where status epilepticus is induced at postnatal day (P) 25 by systemic injection of kainic acid followed by a second status at P39, the author treated P25 animals with dexamethasone shortly after kainic acid-induced status epilepticus to block the seizure-induced inflammation. Kainic acid-induced status epilepticus at P25 caused marked microglia activation within 24 hours. At P39, kainic acid-induced status epilepticus in rats that had no prior seizure (SK) caused modest (2-fold) increase in microglia. In contrast, microglial cells were markedly reactivated (5-fold) in response to a second kainic acid-induced status epilepticus at P39 in animals with prior seizures at P25 (KK). Shortcourse (2-day) dexamethasone significantly improved survival after kainic acid-induced status epilepticus while short-course dexamethasone, significantly decreased seizure induced microglia activation at P25. Inhibition of seizureinduced inflammation by short-course dexamethasone posttreatment mitigated not only the exaggerated microglia activation and cell injury after second kainic acid-induced status epilepticus, but the heightened susceptibility to the seizure later in life. Innate immunity mediated by microglia appears to play a crucial role in initiating and propagating seizure-induced inflammatory responses and may contribute in the pathogenesis of childhood epilepsy. Acute short-term steroid therapy after status epilepticus may be useful to block the epileptogenic process and to abrogate the longterm damaging effects of early-life status epilepticus.
Anti-inflammatory Action of Enriched Environment
Status epilepticus is accompanied by activation of microglia, the resident immune cells of the central nervous system. Activated microglia-which exhibit rounder cell bodies with thicker, retracted dendrites relative to the resting stateundergo rapid proliferation to facilitate efficient immune responses and release inflammatory cytokines and chemokines. Release of these proinflammatory factors facilitate hyperexcitable conditions and contribute to epileptogenesis. Housing in an enriched environment has shown efficacy in ameliorating the detrimental effects of prolonged seizures in developing animals. 63 The author investigated the ability of enriched environment to mitigate seizure-induced microglia activation and behavioral deficits following kainic acid-induced status epilepticus in young mice. Postnatal day 21 CX3CR1EGFP/þ mice were injected intraperitoneally with kainic acid (12 mg/kg) or saline and monitored for progression of seizures for at least 1 hour. Following seizures cessation, mice were placed either singly in a standard vivarium cage (ISO) or in groups of 6-8 in an enriched environment. Only animals that endured status epilepticus (clonic jerks, falls, continuous seizures for more than 30 minutes) were included. Four groups were observed and analyzed in the study: ISO-KA, ISO-PBS, EE-KA, EE-PBS. Complex social and sensory-motor stimulations, provided by exposing young animals to an enriched environment, effectively reversed both a decrease in exploratory behavior and an increase in microglial activation after kainic acid-induced seizures. By reducing microglia activation, the anti-inflammatory action of and proposes the therapeutic efficacy of enriched environment in pediatric epilepsy patients.
Adaptive Immunity and Breakdown of BloodBrain Barrier in Epileptogenesis
Blood-brain barrier disruption has been shown to occur after acute seizures both in human and animal studies. 40, 41, [64] [65] [66] [67] [68] Blood-brain barrier breakdown may not be a mere consequence, but rather a primary cause of seizures. Induction of blood-brain barrier disruption by bile salt or serum albumin in animals 69, 70 and by intra-arterial injection of mannitol in humans 68 increases seizure susceptibility and causes epileptiform discharges or focal seizures. Moreover, peripheral leukocytes appear to promote development of epilepsy by mediating the breakdown of the blood-brain barrier. 40 Suppression of adhesion between leukocytes and endothelial cells either by genetically eliminating adhesion molecules or by blocking the interaction with neutralizing antibodies abrogates the initiation of seizures and progression to epilepsy. 41 Several studies, however, have failed to detect cells of the adaptive immune system (T, B, or natural killer cells) in brain parenchyma of human epileptic tissue or in rats during the acute phase, during the latent period of epileptogenesis (7-10 days after status epilepticus), or in chronic epileptic tissue. 9, 36, 71 Only macrophages of the innate immune system were found acutely or persistently after acute seizures in rat models and scarce T, B, and natural killer cells were detected associated with blood vessels, and rarely in brain parenchyma in human tissue by immunohistochemistry. Also in the postviral infection seizure model in mice, the innate immune responses, specifically TNF-a and IL-6, but not adaptive immune responses, appear to contribute significantly to development of seizures following intracerebral inoculation of neurotropic picornavirus. 72 Possible reasons for the limited involvement of adaptive immunity in these reports may be the use of immunohistochemical detection methods and also that only mature animals or adult epilepsy patients have been included in the study. In a recent study of pediatric patients with chronic intractable focal epilepsy, an extensive perivascular space containing activated microglia, macrophages and T lymphocytes as well as splitting of the basal membrane has been detected. 73 This spongiform microangiopathy affecting arterioles and newly formed porous vascular elements is likely to compromise the blood-brain barrier. 68 Using an unbiased flow cytometric analysis of inflammatory cells, the author has detected significant increases in central nervous system-infiltrating peripheral inflammatory lymphocytes, macrophages and dendritic cells after kainic acid-induced status ("second-hit") in the temporal lobes of mature animals with prior exposure to early-life seizures. To quantify central nervous system-resident microglia and central nervous system-infiltrating macrophages, dendritic cells, and T lymphocytes and to determine the involvement of diverse population of immune cells in epileptogenesis, multicolor flow cytometric analysis of dissociated central nervous system tissue was used. The use of flow cytometry allow us to detect, quantify and follow the time course of breakdown of the bloodbrain barrier and leukocyte infiltration/activation in brains with prior exposure to early-life febrile convulsions (FCs). The author hypothesized that the inflammatory response provoked by initial prolonged convulsions causes activation of glia and disrupts the blood-brain barrier so that the immune system is rapidly reactivated by a second status epilepticus in later life and allows the infiltration of leukocytes, leads to exaggerated microglia activation, heightened seizure susceptibility and exacerbation of neuronal injury. The author hypothesized that recurrent seizures cause blood-brain barrier leakage and infiltration of peripheral leukocytes in the brain. To quantify the numbers of both central nervous systemoriginating and peripherally derived inflammatory cells, the author stained cells with monoclonal antibodies specific for CD45, CD11b, CD11c, CD3, CD4, and CD8 and use multicolor flow cytometry (BD CANTO II Flow Cytometer) to quantify the absolute total cell numbers of central nervous system-resident microglia (CD11b
, and peripheral macrophages (Mj) (CD45 hi CD11b þ CD11c -) The activation status of the various cell types were also examined using standard flow cytometric assays-that is, APCs (antigen presenting cells, upregulated expression of CD40, CD80, CD86, and MHC I and II), and T cells (upregulated expression of CD25, CD44, and CD69). The author's recent results illustrate that she has successfully been able to detect infiltration of a significant number of peripheral leukocytes in the temporal lobe of mice following kainic acid-induced status epilepticus using this flow cytometric approach. Mice subjected to 2 hits of kainic acid (KA/KA) had increased percentages and cell numbers of infiltrating mDCs, lDCs, and macrophages compared to mice subjected to single kainic acid (PBS/KA) and nonseizure controls (PBS/PBS). The author's results also revealed that there are increased numbers of CD4 þ and CD8 þ T cells in the brains of KA/KA mice compared to PBS/KA or PBS/PBS controls.
Innate and Adaptive Immunity in Pathogenesis of Intractable Pediatric Epilepsy
To elucidate the role of brain inflammation and cell death in intractable seizures and neurological morbidity in childhood epilepsy, the author quantified cell death, astrocyte proliferation, microglial activation and cytokine release in brain tissue from patients who underwent epilepsy surgery. Cortical tissue was collected from 13 patients with intractable epilepsy due to focal cortical dysplasia, encephalomalacia, Rasmussen's encephalitis or mesial temporal lobe epilepsy. Sections were processed for immunohistochemistry using markers for neuron, astrocyte, microglia or cellular injury. Cytokine assay was performed on frozen cortices. Controls were autopsy brains from 5 patients without history of neurological diseases. Marked activation of microglia and astrocytes and diffuse cell death were observed in epileptic tissue. Numerous fibrillary astrocytes and their processes covered the entire cortex and converged on to blood vessels, neurons and microglia. An overwhelming number of neurons and astrocytes showed DNA fragmentation and its magnitude significantly correlated with seizure frequency. Thickened microglial processes encased fragmented DNA and the amount of activated microglia inversely correlated with DNA fragmentation. IL-1b, IL-8, IL-12p70 and MIP-1b were significantly increased in the epileptic cortex; IL-6, and MCP-1 were significantly higher in patients with family history of epilepsy. The author showed that active neuroinflammation and marked cellular injury occur in pediatric epilepsy and may play a common pathogenic role in childhood epilepsy of diverse etiologies. The author's findings support the concept that immunomodulation targeting activated microglia and astrocytes may be a novel therapeutic strategy to reduce neurological morbidity and prevent intractable epilepsy. 20 Human studies substantiating the contribution of bloodborne leukocytes in epilepsy development and progression to support the use of anti-inflammatory therapies are lacking. To gain a better understanding of the immunopathogenesis of epilepsy, the author performed flow cytometric characterization of brain-infiltrating and brain-resident immune cells in surgically resected brain tissues from pediatric patients diagnosed with 2 leading causes of intractable epilepsies-focal cortical dysplasia caused by somatic mutation and encephalomalacia due to brain injury. The author demonstrated significant infiltration of the brain parenchyma by activated memory CD4 þ helper and CD8 þ cytotoxic T lymphocytes as well as blood-borne inflammatory myeloid cells. Of note, among the highest number of infiltrating leukocytes were found in children with diagnosis of epileptic encephalopathy including West syndrome and Lennox-Gastaut syndrome. Moreover, the author demonstrated that proinflammatory gd T lymphocytes are concentrated in the epileptogenic zone and their numbers positively correlate with seizure severity, whereas the numbers of brain-infiltrating regulatory T cells (Tregs) inversely correlate with disease severity. These findings are corroborated by studies demonstrating similar activation of innate and adaptive immune responses in the brains of a mouse model of kainic acid-induced status epilepticus. In line with the author's human data, the author showed that gd T cell-deficient mice display less severe seizures, while autologous nTreg depletion worsens seizures and Treg supplementation dampens seizure susceptibility. Uniquely, the author's data support an important pathologic role for bloodderived leukocytes in epileptogenesis and support the development and testing of novel and safe disease-modifying treatments targeting brain-infiltration of peripheral immune cells. To the author's knowledge, this is the first definitive demonstration of the quantification of peripherally derived innate and adaptive immune inflammatory cells in epileptogenic tissue and suggests a potential role for these cells in the pathogenesis of epilepsy.
Summary
Mounting evidence indicates a critical role of immunity and neuroinflammation in the evolution of drug resistant childhood epilepsy. The author's laboratory has shown that kainic acidinduced status epilepticus in juvenile animals cause acute and transient activation of microglia, innate immune cells in the brain. Second hit kainic acid-induced status epilepticus later in life results in markedly exaggerated reactivation of microglia accompanied by heightened susceptibility to a second seizure. Minocycline, dexamethasone or enriched environment posttreatment after first kainic acid-induced status epilepticus attenuates both exaggerated microglia activation and increased seizure susceptibility to later-life seizures, suggesting a causal role of innate immunity in neuronal hyper-excitability and lowered seizure threshold. Blood-brain barrier breakdown and infiltration of peripheral immune cells are demonstrated both in men and mice after recurrent seizures. Highlighted are opposing role of regulatory T cell versus proinflammatory cytotoxic T cells and gd T lymphocytes in pathogenesis of drug-resistant epilepsy. Presence of overwhelming proportion of activated T cells and gd T lymphocytes in the brain parenchyma of children who underwent surgical resection for relentless refractory epilepsy raises an intriguing question whether drug-resistant epileptic encephalopathy be considered an autoimmune disease. The author proposes that immune mechanism in evolution of drug-resistant pediatric epilepsy involves a nonlinear, amplifying feedback loop of innate and adaptive immunity. Microglia in young brain react rapidly and robustly to recurrent seizures by releasing cytokines and chemokines, which then leads to infiltration of professional antigen presenting cells from the periphery and infiltration of T cells. The ongoing, chronic neuroinflammation thus predisposes, precipitates, and perpetuates epileptogenesis in developing brain.
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